Skip to main content
. 2012 Mar;81(3):440–454. doi: 10.1124/mol.111.077040

TABLE 3.

Docking scores for PC2 inhibitors at different binding sites.

Compound Active site Allosteric Site 1 Allosteric Site 3 Type of Inhibition Ki
kcal/mol μM
166830 −5.9 −6.7 −6.6 Competitive 2.1 ± 0.2
166829 −5.3 −6.3 −9.0 Noncompetitive 11.7 ± 1.1
166369 −9.0 −9.8 −8.9 Mixed 7.3 ± 2.3